Celastrol Targets Hsc70‐Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Weitong Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan University, State Key Laboratory of Biotherapy, Chengdu, China. Hauptthemen laut MEDLINE: Triterpenes, HSC70 Heat-Shock Proteins, Bcl-2-Like Protein 11, Senotherapeutics. Die Arbeit nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Senolysis holds promise for geroprotection but is limited by efficacy and safety; here we show that Celastrol, a pentacyclic triterpenoid, surpasses benchmark agents ABT‐263 and fisetin in senolytic potency and elucidate its mechanism and a prodrug strategy to improve safety. Using stress‐ and replication‐induced senescent cells, we demonstrate that Celastrol selectively triggers intrinsic apoptosis—evidenced by viability assays, Annexin V/PI, cleaved caspase‐3 and blockade by the pan‐caspase inhibitor Z‐VAD‐FMK—while ferroptosis is excluded by specific inhibitors. Proteomic, co‐immunoprecipitation/mass spectrometry, biolayer interferometry, ubiquitination assays and RNAi identify Hsc70 as a binding partner; Celastrol disrupts an Hsc70–Bim–CHIP complex, reduces Bim ubiquitination and stabilizes Bim protein, and Bim knockdown attenuates caspase activation and senolysis. In vivo, Celastrol reduces intestinal senescence and extends Drosophila median and maximum lifespan, and mitigates bleomycin‐ and CCl₄‐induced pulmonary and hepatic fibrosis in mice with increased cleaved caspase‐3 in p16⁺ cells. A β‐galactosidase‐activated prodrug (CeGal) preserves efficacy, preferentially releases Celastrol in β‐galactosidase‐high cells, and markedly reduces systemic toxicity, supporting clinical translation of this targeted senolytic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan University, State Key Laboratory of Biotherapy, Chengdu, China.
- West China Hospital, Institute of Anesthesiology Research, Chengdu, China.
ORCID-Profile: Fangfang Wang, Ming Yang, Ying Li
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Sichuan Science and Technology Program
- Open Fund of Development and Regeneration Key Laboratory of Sichuan Province
- National Clinical Research Center for Geriatrics, West China Hospital
Zitieren
APA
Xu, W., Chen, H., Gong, H., Zhao, T., Yang, Y., Wang, F., Huang, N., Yang, M., Gao, N., Li, H., Huang, X., Li, Y., & Xiao, H. (2026). Celastrol Targets Hsc70‐Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis. Phytotherapy Research. https://doi.org/10.1002/ptr.70220
Vancouver
Xu W, Chen H, Gong H, Zhao T, Yang Y, Wang F, et al. Celastrol Targets Hsc70‐Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis. Phytotherapy Research. 2026. doi:10.1002/ptr.70220
BibTeX
@article{Xu2026,
author = {Xu, Weitong and Chen, Honghan and Gong, Hui and Zhao, Tingting and Yang, Yu and Wang, Fangfang and Huang, Ning and Yang, Ming and Gao, Nan and Li, Huan and Huang, Xiaoli and Li, Ying and Xiao, Hengyi},
title = {Celastrol Targets Hsc70‐Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70220}
}
EUVIMED